ABBOTT LABORATORIES — Director's Dealing 2017

Aug 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-08-02

Reporting Person: STARKS DANIEL J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-02	Common shares without par value	M	168413	$28.50	Acquired	6607117	Direct
2017-08-02	Common shares without par value	M	336131	$33.14	Acquired	6943248	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-02	Option (right to buy)	$28.50	M	168413	Disposed	2018-01-03	Common shares (168413)	Direct
2017-08-02	Option (right to buy)	$33.14	M	336131	Disposed	2018-01-03	Common shares (336131)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	258	Indirect

Footnotes

F1: Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.

F2: St. Jude Medical, Inc. stock option that was converted to an Abbott stock option in connection with Abbott's acquisition of St. Jude Medical, in a transaction exempt from Section 16 under Rule 16b-3.